Figure 3
From: Maintenance DFMO Increases Survival in High Risk Neuroblastoma
(a) Event free survival and (b) overall survival for the Stratum 2 intention to treat (ITT) population. (c) Event free survival aRnd (d) overall survival for previously relapsed subjects in Stratum 2. (e) Event free survival and (f) overall survival for previously refractory subjects. (g) Event free survival and (h) overall survival for MYCN amplified versus non-amplified subjects.
